Israeli-Inspired Show Grabs a Few Emmys
Graphic by Angelie Zaslavsky
The Emmys doesn’t have a foreign language category, so Israel’s TV industry had to make do with winning an award by proxy September 21 at the annual red carpet event in Los Angeles.
Dianne Wiest, already a two-time Oscar winner, added an additional statuette to her collection by winning the best supporting actress award for “In Treatment,” HBO’s largely faithful adaptation of the hit 2005 Israeli drama “BeTipul.” The American version of the show features Wiest as Gina Toll, a therapist originally named Gila Abulafia and played on Israeli TV by stage and film veteran Gila Almagor.
Wiest’s victory, over nominees from ABC-TV’s “Grey’s Anatomy,” “Boston Legal” and “Brothers and Sisters,” marked the second Emmy for the Israeli-inspired series. The win followed “In Treatment” performer Glynn Turman’s victory in the guest actor category, announced at the Emmys’ un-televised creative arts ceremony September 13.
Series star Gabriel Byrne, nominated for best actor for his work as psychotherapist Paul Weston, lost in that contest to Bryan Cranston of AMC’s “Breaking Bad.”
Wiest, a 1997 Emmy winner for a guest role on “Road to Avonlea,” which is based on Lucy Maud Montgomery’s “Anne of Green Gables” stories, missed the Sunday night ceremony to perform in the new “All My Sons” revival on Broadway.
Both she and Byrne will return for HBO’s second season of “In Treatment,” which is set to begin filming in New York this season.
This is a moment of great uncertainty. Here’s what you can do about it.
We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover.
This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.
With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.
The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.
Support our mission to tell the Jewish story fully and fairly.
